Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07543068 · ClinicalTrials.gov registry record · NA
Diabetes Prevention by Group Intervention and CGM Use in Pre-diabetic Adults
A NA study, sponsored by Sam Houston State University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07543068 is a NA study that has not yet begun recruiting, run by Sam Houston State University. The registered enrollment target is 20 participants.
The verdict
NCT07543068, a NA study, has not yet begun recruiting, sponsored by Sam Houston State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is being done to find better ways to help people with prediabetes prevent or delay the development of type 2 diabetes. Prediabetes means your blood sugar is higher than normal, but not high enough to be diagnosed with diabetes. It is often silent, but without changes in diet and activity, many people progress to a diagnosis of diabetes within a few years. The study combines two strategies: 1. Group visits - small, regular meetings where patients learn about healthy eating, physical activity, and stress management. 2. Continuous Glucose Monitors (CGMs) - small wearable sensors that measure blood sugar all day and show how food, movement, and sleep affect it in real time. By bringing these two tools together, the research hopes to help participants better understand their own bodies and make lasting lifestyle changes. What is the purpose of this research? The purpose of this research is to find out whether using a CGM device together with group sessions can help people with prediabetes lower their average blood sugar (measured by A1C) and improve confidence in managing their health.
Interventions
- OTHER Combines group sessions and CGM-based behavioral feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07543068
The ClinicalTrials.gov registry entry for NCT07543068 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sam Houston State University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combines group sessions and CGM-based behavioral feedback is the first listed.
NCT07543068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07543068 about?
NCT07543068 is a clinical study titled "Diabetes Prevention by Group Intervention and CGM Use in Pre-diabetic Adults". This study is being done to find better ways to help people with prediabetes prevent or delay the development of type 2 diabetes. Prediabetes means your blood sugar is higher than normal, but not high enough to be diagnosed with diabetes. It is often silent, but without changes in diet and activity,...
What is the current status of trial NCT07543068?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07543068?
The interventions under investigation include: Combines group sessions and CGM-based behavioral feedback (OTHER).
Who is sponsoring clinical trial NCT07543068?
This trial is sponsored by Sam Houston State University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.